Detalhe da pesquisa
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682738
2.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674615
3.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
4.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
5.
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives.
Anticancer Drugs
; 27(10): 917-43, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27400375
6.
Immunotherapy for genitourinary cancer: state of the art and new perspectives.
Anticancer Drugs
; 27(7): 585-99, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27183027
7.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer
; : 102074, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616147
8.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
9.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Cancers (Basel)
; 15(8)2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190322
10.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010650
11.
Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy.
Curr Oncol
; 29(5): 3364-3374, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35621663
12.
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Front Oncol
; 12: 955501, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212433
13.
Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis.
Cancers (Basel)
; 13(6)2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33808533
14.
Managing the unexpected: Carcinosarcoma of the kidney parenchyma A case with the longest follow-up.
Urologia
; 88(3): 251-254, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567506
15.
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Ther Adv Med Oncol
; 13: 17588359211019642, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046089
16.
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer.
Eur J Cancer
; 140: 140-146, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091718
17.
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
J Immunother Cancer
; 8(2)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33060148
18.
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
Cancers (Basel)
; 12(1)2019 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31861942
19.
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.
Ther Adv Med Oncol
; 10: 1758834017745819, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29383035
20.
Treatment of elderly patients with metastatic renal cell carcinoma.
Expert Rev Anticancer Ther
; 16(3): 323-34, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26654225